LifeMD Now Offers Eli Lilly's Foundayo to Eligible Patients Through its Weight Management Program
MT Newswires Live
Apr 10
LifeMD (LFMD) said Friday it is now offering Eli Lilly's (LLY) weight management drug Foundayo to eligible patients through its weight management program.
The company is offering the medicine through its integration with LillyDirect, which allows prescriptions to be fulfilled and dispatched directly to patients, it said.
Shares of LifeMD were up over 1% in Friday premarket activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.